Hospital Pharmacy Optimization Success Stories
The CompleteRx team has successfully partnered with several hospital leadership teams to implement best practices, improve outcomes and decrease operational expenses.
Case Studies
Download these case studies highlighting the benefits of working with a team who understands the importance of team culture and high performance workplaces.
Expired Pharmaceutical Medications: How the Process Works, What It Means for Your Hospital, and What We Learned From a Full Pharmacy Assessment
Hospitals are feeling the strain of drug shortages, rising costs, and overstretched teams. When the workload builds, and purchasing habits
Streamlining Pharmacy Inventory for Savings & Profitability
Situation A pharmacy’s inventory impacts not only the health of its patients but also the financial health of the business.
Antimicrobial Stewardship Program at Work
Situation Over the past several decades, antimicrobial misuse has led to a growing amount of innate resistance to commonly available
Medication Reconciliation Technician Program
Critical Medication Error Statistics According to the U.S. Food and Drug Administration: Medication Reconciliation is not accurate on admissions. Situation
Dual Eligibility Helps Optimize 340B Savings for Hospitals
Situation Orphan drugs are used to treat, prevent, or diagnose an orphan disease, which is a rare disease or condition
Clinical Drug Savings Optimization
Top Financial Challenges for Hospital CEOs According to IBM Watson Health, surveyed hospital CEOs rank the following among their top
Optimizing Infusion Center Revenues & Profitability
Situation Infusion therapy is a vital component of modern healthcare, providing essential treatments for a wide array of conditions, from
Generic Medications Enhance Cost Savings & Compliance
Situation Escalating drug costs pose a significant challenge to healthcare institutions, impacting both the overall health system and patient care.
Oncology Revenue Integrity: $182K Recovered with CompleteRx
Situation As hospitals across the US continue to face rising drug costs, inconsistent reimbursement, and growing regulatory complexity, the need